Roy Abhishek, Samanta Tryambak, Purkait Radheshyam, Mukherji Aritra, Ganguly Sutapa
Department of Paediatric Medicine, North Bengal Medical College and Hospital, Shushrutnagar, Darjeeling, West Bengal, India.
J Coll Physicians Surg Pak. 2013 Mar;23(3):194-8.
To determine the etiology, clinical spectrum and outcome of metabolic liver diseases (MLD) in children admitted in a tertiary care hospital of Eastern India.
An observational study.
Paediatric Liver Clinic and Paediatrics Inpatient Department of Nilratan Sircar Medical College and Hospital, Kolkata, Eastern India, from April 2009 to March 2011.
All children aged 0 - 12 years having characteristic clinical features along with diagnostic hallmark of any MLDs were included in this study and data were collected on a pre-designed proforma. After appropriate management and discharge, all patients were followed-up for next 6 months.
Fifty one children with mean age 4.34 ± 3.78 years (range 2 days - 12 years), male: female ratio 1.55:1, were studied. The etiologies were Wilson's disease (33.33%, n = 17); glycogen storage disorder (23.53%, n = 12); galactosemia (19.61%, n = 10); non-alcoholic fatty liver disease (11.76%, n = 6); Gaucher disease (5.88%, n = 3); mucopolysaccharidoses (3.92%, n = 2) and familial hyperlipoproteinemia type-I (1.96%, n = 1). Jaundice (n = 24) and hepatomegaly (n = 47), was the commonest symptom and sign respectively. Of the 17 non-responders, most were Wilson's disease (n = 7) cases. There was statistical difference in outcome with respect to INR > 1.3 at diagnosis (p = 0.026).
High index of suspicion, early detection and screening, simple dietary modification and cost effective drugs along with good compliance are sufficient to treat and even prevent evolution of most causes of the MLDs.
确定印度东部一家三级护理医院收治的儿童代谢性肝病(MLD)的病因、临床谱及预后。
一项观察性研究。
2009年4月至2011年3月,印度东部加尔各答尼尔拉坦·西卡尔医学院及医院的儿科肝病诊所和儿科住院部。
本研究纳入了所有年龄在0至12岁、具有特征性临床特征以及任何MLD诊断标志的儿童,并通过预先设计的表格收集数据。经过适当治疗和出院后,对所有患者进行了为期6个月的随访。
共研究了51名儿童,平均年龄4.34±3.78岁(范围为2天至12岁),男女比例为1.55:1。病因包括威尔逊病(33.33%,n = 17);糖原贮积病(23.53%,n = 12);半乳糖血症(19.61%,n = 10);非酒精性脂肪性肝病(11.76%,n = 6);戈谢病(5.88%,n = 3);黏多糖贮积症(3.92%,n = 2)和Ⅰ型家族性高脂蛋白血症(1.96%,n = 1)。黄疸(n = 24)和肝肿大(n = 47)分别是最常见的症状和体征。在17例无反应者中,大多数是威尔逊病(n = 7)病例。诊断时国际标准化比值(INR)> 1.3的患者预后存在统计学差异(p = 0.026)。
高度的怀疑指数、早期检测和筛查、简单的饮食调整、具有成本效益的药物以及良好的依从性足以治疗甚至预防大多数MLD病因的进展。